Setanaxib, Placebo tablets clinical trials

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of the NOX1/4 Inhibitor Setanaxib in Patients with Alport Syndrome

This study is testing a new medicine, Setanaxib, for Alport syndrome. We want to see if it's safe, how it works in the body, and if it helps reduce kidney damage and other symptoms. Half the participants will get the new medicine, and half will get a dummy pill.